The science of evaluation of adverse events associated with vaccination

Seminars in Pediatric Infectious Diseases

Volumn 13, Issue 3, 2002, Pages 205-214

  Halsey, Neal A ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; INFLUENZA VACCINE; LIVE VACCINE; MEASLES VACCINE; ORAL POLIOMYELITIS VACCINE; TETANUS TOXOID; VACCINE; MEASLES MUMPS RUBELLA VACCINE;

ARTICLE; AUTISM; BACTERIUM CONTAMINATION; CEREBELLAR ATAXIA; CORRELATION ANALYSIS; DEATH; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; DRUG PACKAGING; DRUG SAFETY; ENCEPHALITIS; HUMAN; IMMUNOCOMPETENCE; INJECTION PAIN; INSULIN DEPENDENT DIABETES MELLITUS; OSTEOMYELITIS; PARALYSIS; PATHOGENESIS; RISK ASSESSMENT; SYNCOPE; TISSUE INJURY; VACCINATION; DRUG SURVEILLANCE PROGRAM; IMMUNOLOGY; INFANT; PRESCHOOL CHILD; REVIEW; RISK; STANDARD;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AUTISTIC DISORDER; CHILD, PRESCHOOL; HUMANS; INFANT; MEASLES-MUMPS-RUBELLA VACCINE; RISK; VACCINATION; VACCINES;

EID: 0036628943     PISSN: 10451870     EISSN: None     Source Type: Journal    
DOI: 10.1053/spid.2002.125864     Document Type: Article

References (69)

1. Complications of smallpox vaccination, 1968: Results of ten statewide surveys
2. Measles-mumps-rubella vaccine and autistic spectrum disorder: Report from the New Challenges in Childhood Immunizations Conference convened in Oak Brook, IL, June 12-13, 2000
3. Osteitis caused by bacillus Calmette-Guerin vaccination: A retrospective analysis of 222 cases
4. Measles pneumonia in childhood leukemia
5. Centers for Disease Control and Prevention: Measles pneumonitis following measles-mumps-rubella vaccination of a patient with HIV infection, 1993
6. Viruses and multiple sclerosis
7. Application of polymerase chain reaction to the diagnosis of infectious diseases
8. Controlled trial of live measles vaccine: Effects of age, history of measles in siblings, prevaccine antibody, and human-globulin on symptomatic and immune responses
9. Evaluating the safety of combination vaccines
10. The Vaccine Adverse Event Reporting System (VAERS)
11. Lack of an apparent association between intussusception and wild or vaccine rotavirus infection
12. Intussusception among infants given an oral rotavirus vaccine
13. Perspectives on the design and analysis of prelicensure trials: Bridging the gap to postlicensure studies
14. Combination vaccines: Postlicensure safety evaluation
15. The Vaccine Safety Datalink: Immunization research in health maintenance organizations in the USA
16. Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases
17. Taking the sting out of shots: Control of vaccination-associated pain and adverse reactions
18. Syncope after immunization
19. Active Immunization
20. WHO Global Programme for Vaccines and Immunization, module 4. How to give a hepatitis B immunization
21. General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP)
22. Provocation of poliomyelitis by multiple injections
23. Intramuscular injections within 30 days of immunization with oral polio-virus vaccine - A risk factor for vaccine-associated paralytic poliomyelitis
24. World Health Organization: Vaccine supply and quality: Surveillance of adverse events following immunization
25. Abscesses complicating DTP vaccination
26. The cutter incident: Poliomyelitis following formaldehyde-inactivated poliovirus vaccination in the United States during the spring of 1955. II. Relationship of poliomyelitis to Cutter vaccine
27. Regulation and testing of vaccines
28. Overview of vaccine manufacturing and quality assurance
29. Prevention of varicella. Recommendations of the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention
30. Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease
31. Does SV40 infection contribute to the development of human cancers?
32. Yellow fever
33. Notice to readers: Public Health Service recommendations for the use of vaccines manufactured with bovine-derived materials
34. Evolving scientific and regulatory perspectives on cell substrates for vaccine development
35. A randomized comparison of reactogenicity and immunogenicity of two whole cell pertussis vaccines
36. An assessment of thimerosal use in childhood vaccines
37. Technical report: Mercury in the environment: Implications for pediatricians
38. Joint Statement of the American Academy of Pediatrics (AAP) and the United States Public Health Service (PHS) on thimerosal in vaccines on infant hepatitis B vaccination practices
39. Balancing risks and benefits: Primum non nocere is too simplistic
40. Stevens-Johnson syndrome after vaccination
41. Anaphylaxis to measles, mumps, and rubella vaccine mediated by IgE to gelatin
42. Safe administration of the measles vaccine to children allergic to eggs
43. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977
44. The Guillain-Barre syndrome and the 1992-1993 and 1993-1994 influenza vaccines
45. Recommendations of the Advisory Committee on Immunization Practices (ACIP): Use of vaccines and immune globulins for persons with altered immunocompetence
46. Immunization of HIV-infected children
47. Measles pneumonitis following measles-mumps-rubella vaccination of a patient with HIV infection, 1993
48. The postmarketing safety profile of varicella vaccine
49. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: Mechanism for autoimmunity
50. Hepatitis B vaccine and central nervous system demyelinating diseases
51. Vaccinations and the risk of relapse in multiple sclerosis
52. Hepatitis B vaccination and the risk of multiple sclerosis
53. The timing of immunization affects the development of diabetes in rodents
54. BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide
55. Prevalence and incidence of insulin-dependent diabetes
56. Association between type 1 diabetes and Haemophilus influenzae type b vaccination: Birth cohort study
57. Childhood immunizations and type 1 diabetes: Summary of an Institute for Vaccine Safety Workshop
58. Ileal-lymphoidnodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children
59. Measles virus persistence in specimens of inflammatory bowel disease and autism cases
60. Autism and measles, mumps and rubella vaccine: No epidemiological evidence for a causal association
61. Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: A time trend analysis
62. Time trends in autism and in MMR immunization coverage in California
63. Vaccine safety
64. Combination vaccines: Defining and addressing current safety concerns
65. Addressing parents' concerns: Do multiple vaccines overwhelm or weaken the infant's immune system?